Humacyte, Inc.
HUMA
$2.53
$0.135.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.14M | -20.94M | -39.20M | -56.66M | -31.90M |
| Total Depreciation and Amortization | 1.83M | 1.81M | 1.81M | 1.78M | 1.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.01M | -4.94M | 11.07M | 29.54M | 7.42M |
| Change in Net Operating Assets | -9.56M | -2.50M | 3.41M | 4.06M | -4.66M |
| Cash from Operations | -28.60M | -26.58M | -22.91M | -21.29M | -27.35M |
| Capital Expenditure | -228.00K | -63.00K | -934.00K | -184.00K | -391.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -228.00K | -63.00K | -934.00K | -184.00K | -391.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -687.00K | -673.00K | -659.00K | -644.00K | -603.00K |
| Issuance of Common Stock | 47.43M | 50.16M | 495.00K | 787.00K | 43.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 1.52M | 1.01M | -610.00K | 20.00M |
| Cash from Financing | 46.74M | 51.01M | 849.00K | -467.00K | 62.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.91M | 24.37M | -22.99M | -21.94M | 35.06M |